---
schema_version: "secwatch.filing_event.v1"
accession: "0001568651-23-000043"
form_type: "8-K"
ticker: "OSCR"
cik: "0001568651"
company_name: "Oscar Health, Inc."
filed_at: "2023-08-08T23:59:59+00:00"
generated_at: "2026-06-12T01:54:53.897847+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Oscar Health Q2 2023: net loss narrows to $15.4M; Adj EBITDA turns positive at $35.6M; CFO Blackley appointed

## Summary
- Net loss of $15.4M improved $96.7M YoY; Adjusted EBITDA $35.6M vs -$75.8M YoY.
- MLR improved 230 bps YoY to 79.9%; InsuranceCo Combined Ratio improved 500 bps to 96.7%.
- Premiums earned $1.5B (+48% YoY); Direct and Assumed Policy Premiums $1.6B (-3% YoY).
- Full-year 2023 guidance tightened: MLR towards low-end of 82-84%, Adj EBITDA towards high-end of -$175M to -$75M.
- R. Scott Blackley returns as CFO effective Aug 14; Sid Sankaran steps down but stays on Board.

## SEC filing metadata
- accession: 0001568651-23-000043
- form_type: 8-K
- ticker: OSCR
- cik: 0001568651
- company_name: Oscar Health, Inc.
- filed_at: 2023-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1568651/000156865123000043/0001568651-23-000043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1568651/000156865123000043/oscr-20230802.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001568651-23-000043
- JSON: https://secwatch.observer/filing/0001568651-23-000043.json
- Plain text: https://secwatch.observer/filing/0001568651-23-000043.txt

## Key facts
- Earnings Releases
  Oscar Health, Inc. updated its full year 2023 guidance (reaffirmed).
  - Period: full year 2023
  - Guidance: reaffirmed
  - Result: guidance update
  source text: Oscar is reaffirming its full year 2023 outlook across all metrics as provided in its financial results press release dated February 9, 2023, with MLR now projected to be towards the low-end of the 82% - 84% range and Adjusted EBITDA 1 projected to be towards the high-end of the ($175) million - ($75) million range, towards a ($75) million loss.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1568651/000156865123000043/0001568651-23-000043-index.htm
- Executive change
  R. Scott Blackley changed role as Chief Financial Officer at Oscar Health, Inc..
  - Action: will become
  - Role: Chief Financial Officer
  source text: Effective August 14, 2023, R. Scott Blackley will become the Company’s Chief Financial Officer (“CFO”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1568651/000156865123000043/0001568651-23-000043-index.htm
- Executive change
  Siddhartha Sankaran departed as Chief Financial Officer at Oscar Health, Inc..
  - Role: Chief Financial Officer
  source text: Mr. Siddhartha Sankaran will remain CFO through that date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1568651/000156865123000043/0001568651-23-000043-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.